Effectiveness of Messenger RNA Vaccines against SARS-CoV-2 Infection in Hemodialysis Patients: A Case–Control Study

Patients with end-stage kidney disease (ESKD) are at increased risk for SARS-CoV-2 infection and its complications compared with the general population. Several studies evaluated the effectiveness of COVID-19 vaccines in the dialysis population but showed mixed results. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkadi, Mohamad M., Hamad, Abdullah, Ghazouani, Hafedh, Elshirbeny, Mostafa, Ali, Mohamed Y., Ghonimi, Tarek, Ibrahim, Rania, Abuhelaiqa, Essa, Abou-Samra, Abdul Badi, Al-Malki, Hassan, Butt, Adeel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863461/
https://www.ncbi.nlm.nih.gov/pubmed/36679894
http://dx.doi.org/10.3390/vaccines11010049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863461/
https://www.ncbi.nlm.nih.gov/pubmed/36679894
http://dx.doi.org/10.3390/vaccines11010049

Ejemplares similares